Koye Pharma next on Warburg's health play
Published on: March 31, 2026, 11:59 p.m. | Source: The Economic Times
Global private equity fund Warburg Pincus is nearing a deal to buy Koye Pharma. The Mumbai-based drugmaker focuses on women's health, respiratory care, and anti-diabetes drugs. This acquisition, valued at approximately ₹300 crore, marks Warburg Pincus's third investment in India's growing medicine market. Koye Pharma has shown strong growth recently, with sales around ₹160 crore.
